It was great to welcome Prof. Ulrike Köhl, Director of the Fraunhofer Institute for Cell Therapy and Immunology, and Paul Franz from Fraunhofer IZI to NecstGen! Over the past two days, we provided a facility tour and had inspiring discussions on potential collaboration.
Our conversations focused on ATMP development and GMP manufacturing, key areas where Fraunhofer IZI and NecstGen are committed to driving progress. From process optimisation to clinical translation, plenty of common ground exists to explore.
As non-profit organisations, both Fraunhofer IZI and NecstGen are driven by a shared mission: enabling the development of advanced therapies and supporting innovation in cell and gene therapy. It’s always inspiring to exchange ideas with like-minded partners who put science and patient impact first.
